SACHDEV RAKESH 4

What Happened

• Rakesh Sachdev, a member of Edgewell Personal Care’s Board of Directors, received an award of 7,817 restricted stock equivalents (derivative award) on February 5, 2026. The reported acquisition price is $0.00, so the Form 4 lists a $0 transaction value. This was an award/grant (transaction code A), not an open-market buy or sale.

Key Details

• Transaction date: 2026-02-05 (Code A — award/grant)
• Amount: 7,817 restricted stock equivalents; reported price $0.00 (total $0 on the Form 4)
• Shares owned after transaction: not specified in this filing
• Footnote: the restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual shareholders’ meeting unless Sachdev elects to defer conversion until he leaves the Board
• Filing date: 2026-02-09 — filed on time under Form 4 deadlines

Context

• Restricted stock equivalents are a form of equity compensation for directors and convert into actual shares later per the footnote; they are not an immediate cash purchase or sale. Such awards are common for non-employee directors as part of compensation and do not, by themselves, indicate buying or selling sentiment.